Facets (new session)
Description
Metadata
Settings
owl:sameAs
Inference Rule:
b3s
b3sifp
dbprdf-label
facets
http://dbpedia.org/resource/inference/rules/dbpedia#
http://dbpedia.org/resource/inference/rules/opencyc#
http://dbpedia.org/resource/inference/rules/umbel#
http://dbpedia.org/resource/inference/rules/yago#
http://dbpedia.org/schema/property_rules#
http://www.ontologyportal.org/inference/rules/SUMO#
http://www.ontologyportal.org/inference/rules/WordNet#
http://www.w3.org/2002/07/owl#
ldp
oplweb
skos-trans
virtrdf-label
None
About:
SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease
Goto
Sponge
NotDistinct
Permalink
An Entity of Type :
schema:ScholarlyArticle
, within Data Space :
covidontheweb.inria.fr
associated with source
document(s)
Type:
Academic Article
research paper
schema:ScholarlyArticle
New Facet based on Instances of this Class
Attributes
Values
type
Academic Article
research paper
schema:ScholarlyArticle
isDefinedBy
Covid-on-the-Web dataset
has title
SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease
Creator
Liu, Lihong
Wang, Pengfei
Wang, Qian
Yu, Jian
Luo, Yang
Sodroski, Joseph
Ho, David
Laracy, Justin
Nair, Manoj
Yin, Michael
Yuan, Ting
Mori, Kanako
Purpura, Lawrence
Solis, Axel
Yamashita, Masahiro
Source
BioRxiv
abstract
We studied plasma antibody responses of 35 patients about 1 month after SARS-CoV-2 infection. Titers of antibodies binding to the viral nucleocapsid and spike proteins were significantly higher in patients with severe disease. Likewise, mean antibody neutralization titers against SARS-CoV-2 pseudovirus and live virus were higher in the sicker patients, by ~5-fold and ~7-fold, respectively. These findings have important implications for those pursuing plasma therapy, isolation of neutralizing monoclonal antibodies, and determinants of immunity.
has issue date
2020-06-14
(
xsd:dateTime
)
bibo:doi
10.1101/2020.06.13.150250
has license
biorxiv
sha1sum (hex)
8ff9e2360f815a3c0f97e51afda3679962bfd0d8
schema:url
https://doi.org/10.1101/2020.06.13.150250
resource representing a document's title
SARS-CoV-2 Neutralizing Antibody Responses Are More Robust in Patients with Severe Disease
schema:publication
bioRxiv
resource representing a document's body
covid:8ff9e2360f815a3c0f97e51afda3679962bfd0d8#body_text
is
schema:about
of
named entity 'Patients'
named entity 'virus'
named entity 'Disease'
named entity 'SARS-CoV-2'
named entity 'SARS-CoV'
named entity 'antibodies'
named entity 'protein'
named entity 'SARS-CoV-2'
named entity 'plasma'
named entity 'blood collection'
named entity 'antibodies'
named entity 'titer'
named entity 'antibodies'
named entity 'plasma'
named entity 'virus'
named entity 'immunoassay'
named entity 'SARS-CoV'
named entity 'pseudovirus'
named entity 'SARS-CoV-2'
named entity 'virus'
named entity 'SARS-CoV'
named entity 'plasma'
named entity 'intensive care unit'
named entity 'Cross-reactive'
named entity 'antibodies'
named entity 'plasma'
named entity 'convalescent plasma'
named entity 'serum samples'
named entity 'infection'
named entity 'binding antibody'
named entity 'neutralizing antibodies'
named entity 'monoclonal antibodies'
named entity 'viremia'
named entity 'SARS-CoV'
named entity 'serologic'
named entity 'SARS-CoV'
named entity 'virus'
named entity 'antibodies'
named entity 'plasma'
named entity 'virus'
named entity 'Neutralizing Antibody'
named entity 'pseudovirus'
named entity 'ACE2'
named entity 'SARS-CoV-2'
named entity 'plasma'
named entity 'serum samples'
named entity 'glycoprotein'
named entity 'Sarbecovirus'
named entity 'neutralizing antibodies'
named entity 'severe acute respiratory syndrome coronavirus 2'
named entity 'coronaviruses'
named entity 'virus'
named entity 'SARS-CoV-2'
named entity 'SARS-CoV-2'
named entity 'LOG'
named entity '3 4'
named entity 'virus'
named entity 'PCR'
named entity 'pseudovirus'
named entity 'plasma'
named entity 'SARS-CoV'
named entity 'antibodies'
named entity 'neutralizing antibody'
named entity 'non-human primates'
named entity 'plasma'
named entity 'antibody'
named entity 'SARS-CoV-2'
named entity 'plasma'
named entity 'HIV-1'
named entity 'virus'
◂◂ First
◂ Prev
Next ▸
Last ▸▸
Page 1 of 3
Go
Faceted Search & Find service v1.13.91 as of Mar 24 2020
Alternative Linked Data Documents:
Sponger
|
ODE
Content Formats:
RDF
ODATA
Microdata
About
OpenLink Virtuoso
version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software